MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its research and diagnostic antibodies unit AbD Serotec has signed a two year contract for the supply of custom monoclonal antibodies with Research Councils UK Shared Services Centre Limited (RCUK SSC Ltd). RCUK SSC Ltd has been set up by the seven Research Councils […]
Custom siRNA Synthesis Offers Research Labs Unique Flexibility for Designing Experiments. Huntsville, AL – Eurofins MWG Operon now offers siMAX siRNA synthesis directly to customers in the US and Canada and through its vast distributor network throughout the Americas. The launch of siMAX siRNA for use in RNAi gene silencing experiments is designed to offer […]
Charlottesville, Virginia – Global Cell Solutions (GCS) and VWR International, LLC, a global laboratory supply and distribution company, announced they have entered into a non-exclusive North American distribution agreement. Under the terms, VWR will distribute GCS’s portfolio of GEM™ magnetic microcarrier products offered with a wide variety of cell adhesion coatings. The magnetic GEM microcarrier […]
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY™ LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification. The new on-line microRNA qPCR assay design software supports the need […]
Epicentre Biotechnologies announced the availability of the new ScriptSeq™ mRNA-Seq Library Preparation Kit (Illumina-compatible). Madison, Wis. – Today, Epicentre Biotechnologies announced the availability of the new ScriptSeq™ mRNA-Seq Library Preparation Kit (Illumina-compatible). The kit uses a unique, patented terminal-tagging technology that simplifies strand-specific tagging and the preparation of directional mRNA-Seq libraries from rRNA-depleted or poly(A) […]
CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions,today announced that it has signed an exclusive license agreement for ErrASE, a commercially available DNA error-correction kit developed by Novici Biotech LLC to increase accuracy and accelerate the pace of research in the field of synthetic biology. Under the terms […]
Broad Patent Covers the Revolutionary Sequence Design Technology Embedded in DNA2.0’s Free Gene Design Application Menlo Park, CA – BIOTECHNICA (https://www.biotechnica.de/), Hannover: DNA2.0 (https://www.dna20.com), the leading gene synthesis and protein engineering company, today announced that it has attained a patent through the U.S. Patent and Trade Office for the dynamic drag-and-drop- sequence functionality to create […]
Combination of Technologies Set to Increase Success Rates in Drug Development MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today the acquisition of the private German company Sloning BioTechnology GmbH, a biotechnology company developing new methods of synthetic biology. The transaction will make MorphoSys the sole source of Sloning’s state-of-the-art Slonomics technology, which dramatically […]
Product Developed Under License and Alliance Agreement with Geron MENLO PARK, Calif. – Geron Corporation (Nasdaq: GERN) today announced that GE Healthcare has launched the first human cellular assay product for use in drug discovery and toxicity screening, developed under a license and alliance agreement between the two companies. This first commercially available product is […]
Enabling improved accuracy in drug safety through better toxicology testing Chalfont St.Giles, October 5th, 2010 – GE Healthcare, a unit of General Electric Company (NYSE: GE), announces the availability of human cardiomyocytes, or heart muscle cells, that provide a more readily available and biologically-relevant alternative to current cell models and primary cells used in drug […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
